tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Blogger Opinions & Sentiment

528 Followers

Blogger Sentiment

Bullish: 75.00%
Sector Average
Bullish
FDMT Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% Investing
25% SeekingAlpha
25% Zacks
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

4D Molecular: 'Buy' Wet-AMD Study Readouts 2027 And DME Expansion Opportunity
SeekingAlpha
4d Molecular Therapeutics CEO David Kirn sells $737k in stock
Investing
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of FDMT?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of FDMT?
    Currently there's no blogger sentiment for FDMT.
    What Is FDMT’s Blogger Sentiment?
    FDMT’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for FDMT?
      The most recent blogger prediction for FDMT was made by Zacks Equity Research, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          TEMTempus AI, Inc. Class A
          DRTSAlpha Tau Medical Ltd
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics